ConductScience.org, home

Paper33294147

Empagliflozin improves chronic hypercortisolism-induced abnormal myocardial structure and cardiac function in mice.

Zhang QQ and 6 others. Ther Adv Chronic Dis, 2020. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Empagliflozin improves chronic hypercortisolism-induced abnormal myocardial structure and cardiac function in mice. Papers, record 33294147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33294147

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Empagliflozin improves chronic hypercortisolism-induced abnormal myocardial structure and cardiac function in mice.
PubMed
Journal
Ther Adv Chronic Dis
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
0.93
iCite
Revised in PubMed
2022-04-18
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang QQQing-Qing
2Li GQGuo-Qing
3Zhong YYi
4Wang JJie
5Wang ANAn-Ning
6Zhou XXiao
7Mao XMXiao-Ming

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127085585Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes.Clin Ther2016https://conductscience.org/library/papers/27085585PubMed
222807233Prevalence of oral glucocorticoid usage in the United States: a general population perspective.Arthritis Care Res (Hoboken)2013https://conductscience.org/library/papers/22807233PubMed
330868176Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program.Diabetologia2019https://conductscience.org/library/papers/30868176PubMed
431912605Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF).Eur J Heart Fail2020https://conductscience.org/library/papers/31912605PubMed
526378978Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.N Engl J Med2015https://conductscience.org/library/papers/26378978PubMed
619933822Cardiac dysfunction is reversed upon successful treatment of Cushing's syndrome.Eur J Endocrinol2010https://conductscience.org/library/papers/19933822PubMed
727585437Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus.Cardiovasc Diabetol2016https://conductscience.org/library/papers/27585437PubMed
830710997SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart.Cardiovasc Diabetol2019https://conductscience.org/library/papers/30710997PubMed
930062155Empagliflozin Prevents Worsening of Cardiac Function in an Experimental Model of Pressure Overload-Induced Heart Failure.JACC Basic Transl Sci2017https://conductscience.org/library/papers/30062155PubMed
1028428225Empagliflozin and Kinetics of Renal Glucose Transport in Healthy Individuals and Individuals With Type 2 Diabetes.Diabetes2017https://conductscience.org/library/papers/28428225PubMed
1122728347The burden of Cushing's disease: clinical and health-related quality of life aspects.Eur J Endocrinol2012https://conductscience.org/library/papers/22728347PubMed
1218269563Assessment of left ventricular diastolic function and Tei index by tissue Doppler imaging in patients with Cushing's Syndrome.Echocardiography2008https://conductscience.org/library/papers/18269563PubMed
1327289126CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" Hypothesis.Diabetes Care2016https://conductscience.org/library/papers/27289126PubMed
1425611208Empagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2 Exerts Anti-Inflammatory and Antifibrotic Effects on Experimental Diabetic Nephropathy Partly by Suppressing AGEs-Receptor Axis.Horm Metab Res2015https://conductscience.org/library/papers/25611208PubMed
1523327928Decreased autonomic modulation of heart rate and altered cardiac sympathovagal balance in patients with Cushing's syndrome: role of endogenous hypercortisolism.Neuroendocrinology2013https://conductscience.org/library/papers/23327928PubMed
1622004909Increased myocardial fibrosis and left ventricular dysfunction in Cushing's syndrome.Eur J Endocrinol2012https://conductscience.org/library/papers/22004909PubMed
1730571233Angiotensin II Causes Biphasic STAT3 Activation Through TLR4 to Initiate Cardiac Remodeling.Hypertension2018https://conductscience.org/library/papers/30571233PubMed
1821470280Specific electrocardiographic features associated with Cushing's disease.Clin Endocrinol (Oxf)2011https://conductscience.org/library/papers/21470280PubMed
1932865377Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.N Engl J Med2020https://conductscience.org/library/papers/32865377PubMed
2028132924Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts.Free Radic Biol Med2017https://conductscience.org/library/papers/28132924PubMed

See all 39 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
42277628Chemokine-Guided Biomimetic Mn/Ce Nanozymes for Immunomodulation and Cardioprotection in Doxorubicin-Induced Cardiomyopathy.Adv Healthc Mater2026https://conductscience.org/library/papers/42277628PubMed
42133559Potential Mechanisms of Sodium-Glucose Cotransporter 2 Inhibitors in Regulating Cardiac and Renal Fibrosis.Cardiorenal Med2026https://conductscience.org/library/papers/42133559PubMed
40542280Effects of SGLT2 ablation or inhibition on corticosterone secretion in high-fat-fed mice: exploring a nexus with cytokine levels.Diabetologia2025https://conductscience.org/library/papers/40542280PubMed
37691190Sodium-glucose Cotransporter 2 Inhibitors and Pathological Myocardial Hypertrophy.Curr Drug Targets2023https://conductscience.org/library/papers/37691190PubMed
37658280Sodium Glucose Transporter-2 Inhibitors (SGLT2Is)-TLRs Axis Modulates Diabetes.Cell Biochem Biophys2023https://conductscience.org/library/papers/37658280PubMed
37535237The anti-inflammatory and immunological properties of SGLT-2 inhibitors.J Endocrinol Invest2023https://conductscience.org/library/papers/37535237PubMed
36749400Dapagliflozin protects against dilated cardiomyopathy progression by targeting NLRP3 inflammasome activation.Naunyn Schmiedebergs Arch Pharmacol2023https://conductscience.org/library/papers/36749400PubMed
36232292Empagliflozin Preserves Skeletal Muscle Function in a HFpEF Rat Model.Int J Mol Sci2022https://conductscience.org/library/papers/36232292PubMed
36110847Role of the CCL2-CCR2 axis in cardiovascular disease: Pathogenesis and clinical implications.Front Immunol2022https://conductscience.org/library/papers/36110847PubMed
35814223Anti-Arrhythmic Effects of Sodium-Glucose Co-Transporter 2 Inhibitors.Front Pharmacol2022https://conductscience.org/library/papers/35814223PubMed
35628443Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Regulation of Inflammatory Processes in Animal Models.Int J Mol Sci2022https://conductscience.org/library/papers/35628443PubMed
35295328Emerging Roles of Sodium Glucose Cotransporter 2 (SGLT-2) Inhibitors in Diabetic Cardiovascular Diseases: Focusing on Immunity, Inflammation and Metabolism.Front Pharmacol2022https://conductscience.org/library/papers/35295328PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene
REN5972PubTator's text mininghttps://conductscience.org/library/genes/5972NCBI Gene
SLC5A26524PubTator's text mininghttps://conductscience.org/library/genes/6524NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33294147

GET https://conductscience.org/api/papers/v1/33294147/references?page=2